The healthcare technology sector is rapidly evolving, with companies leveraging AI, telemedicine, and digital platforms to revolutionize healthcare delivery. This article highlights seven public companies leading this transformation, each focusing on different aspects of healthcare innovation, from virtual care to automated medication management and value-based care models. Learn about their unique approaches, market positions, and growth prospects.
TeleVox, a leading provider of patient relationship management (PRM) platforms, will demonstrate its Practice Edition and AI-enhanced Website Solution at the MGMA Leaders Conference in Denver. The company’s solutions aim to address key challenges faced by healthcare providers, including inefficient scheduling, poor communication, and low patient retention.
The global fetal Doppler market is experiencing robust growth, driven by technological advancements, increasing demand for prenatal care, and the rising prevalence of pregnancy-related complications. Wireless technologies, improved probe accuracy, and enhanced portability are making fetal Doppler devices more accessible and user-friendly, leading to increased adoption in both clinical and home settings. The market is expected to reach US$ 488.3 million by 2034, with North America dominating the region.
The global hospital lights market is projected to flourish at a robust CAGR of 5.8% from 2024 to 2034, reaching US$ 14.7 billion in revenue by the end of the forecast period. This growth is primarily driven by the increasing focus on circadian lighting and the integration of UV-C disinfection technology into hospital lighting systems. Key market players like Philips Lighting, GE Healthcare, and Signify N.V. are leading the way with innovative lighting solutions tailored to the specific needs of healthcare facilities.
The global clinical trial software market is projected to grow at a CAGR of 14.3% from 2024 to 2031, reaching a valuation of US$ 2.3 billion. This growth is driven by the increasing adoption of digital health solutions, especially in the wake of the COVID-19 pandemic, and a growing demand for patient-centric clinical trial solutions.
Clover Health’s subsidiary, Counterpart Health, has secured a multi-year agreement with Iowa Clinic to utilize its AI-driven solution, Counterpart Assistant, for managing Medicare Advantage and Medicare Shared Savings Program patients. The agreement aims to improve clinical outcomes and provide financial benefits for both Iowa Clinic and its network partners.
Clover Health’s stock jumped after its subsidiary, Counterpart Health, signed a multi-year agreement with The Iowa Clinic to provide its cloud-based software platform for Medicare Advantage and Shared Savings Program patients. The deal highlights Clover Health’s commitment to innovative healthcare solutions and could significantly impact its future growth.
Health tech startup Innovaccer is in advanced discussions to secure up to $250 million in funding, valuing the company between $2.5 billion and $3 billion. The investment would support the integration and analysis of patient data across various healthcare settings. Innovaccer’s cloud-based platform aims to enhance healthcare efficiencies and accelerate industry growth.
Experts gathered at Samsung Medical Center in Seoul to discuss the future of health and the role of AI-powered wearables in driving industry growth. They highlighted the value of comprehensive health data, early disease detection, and the need for Samsung to embrace AI and promote behavioral change. By leveraging insights from wearables and AI, individuals can empower themselves to take proactive steps towards improving their health and well-being.
In the latest episode of Inside Israeli Innovation, we dive into the groundbreaking technologies and innovative startups from Israel. Join Maayan Hoffman as she unravels the latest tech trends, interviews industry leaders, and showcases Israeli tech’s impact on various sectors.
